Novel Coronavirus (SARS-CoV-2/COVID-19)
Hospitals and health systems work hard every day to make care more cost-effective and efficient for their patients, at the same time that they are caring for the nation’s most complex and resource-intensive patients. This has been especially true during the COVID-19 pandemic as hospitals and health…
This presentation helps health care leaders talk with community groups about the vaccine and answer some frequently asked questions.
Hospitals and health systems work hard every day to provide great care in the most cost effective way. At the same time, many patients are sicker than before and require more complex and intense care. This has been especially true during COVID-19. This presentation uses AHA’s new Cost of…
Hospitals and health systems have worked hard to address workforce challenges as the COVID-19 surges continue, but are running out of options and need Congress’ help, writes Robyn Begley, AHA chief nursing officer and CEO of the American Organization for Nursing Leadership, in MedPage Today.
The AHA released a new COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
Treatment with subcutaneous interferon beta-1a plus remdesivir was not superior to treatment with remdesivir alone in a clinical trial that enrolled 969 hospitalized adults with COVID-19 pneumonia in the United States, Japan, Mexico, Singapore and South Korea, the National Institutes of Health…
The Health Resources and Services Administration Oct. 21 will host the last in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds.
Working in health care delivery can be stressful and tiring under normal circumstances. And the COVID-19 pandemic has exerted incredible pressures on the emotional and physical well-being of our health care professionals.
The Department of Health and Human Services has renewed the COVID-19 public health emergency declaration for another 90 days effective Oct. 18.
The National Institutes of Health awarded a total of $78 million in funding to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, with the goal of bringing to market as soon as this year new home and point-of-care tests that can detect multiple respiratory infections.